{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:54Z","timestamp":1761894954076},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11926-009-0039-8","type":"journal-article","created":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T01:51:07Z","timestamp":1250473867000},"page":"278-283","source":"Crossref","is-referenced-by-count":5,"title":["Assessment and treatment of psoriatic spondylitis"],"prefix":"10.1007","volume":"11","author":[{"given":"Peter","family":"Nash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,18]]},"reference":[{"key":"39_CR1","first-page":"320","volume-title":"Bone and Joint Imaging","author":"D. Resnick","year":"1989","unstructured":"Resnick D, Niwayama G: Psoriatic arthritis. In Bone and Joint Imaging. Edited by Resnick D. Philadelphia: WB Saunders; 1989:320\u2013328."},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","volume":"57","author":"P.S. Helliwell","year":"1998","unstructured":"Helliwell PS, Hickling P, Wright V: Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, and reactive arthritis? Ann Rheum Dis 1998, 57:135\u2013140.","journal-title":"Ann Rheum Dis"},{"key":"39_CR3","first-page":"1","volume":"16","author":"D.D. Gladman","year":"1993","unstructured":"Gladman DD, Brubacher B, Buskila D, et al.: Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med 1993, 16:1\u20137.","journal-title":"Clin Invest Med"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.51.1.73","volume":"51","author":"C. Salvarani","year":"1992","unstructured":"Salvarani C, Macchioni P, Cremonesi T, et al.: The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 1992, 51:73\u201377.","journal-title":"Ann Rheum Dis"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ard.61.7.650","volume":"61","author":"K. Laiho","year":"2002","unstructured":"Laiho K, Kauppi M: The cervical spine in patients with psoriatic arthritis. Ann Rheum Dis 2002, 61:650\u2013652.","journal-title":"Ann Rheum Dis"},{"key":"39_CR6","first-page":"1431","volume":"33","author":"P. Nash","year":"2006","unstructured":"Nash P: Therapies for axial disease in psoriatic arthritis. A systematic review. J Rheumatol 2006, 33:1431\u20131434.","journal-title":"J Rheumatol"},{"key":"39_CR7","first-page":"1733","volume":"34","author":"D.D. Gladman","year":"2007","unstructured":"Gladman DD, Inman RD, Cook RJ, et al.: International Spondyloarthritis Interobserver Reliability Exercise\u2014The INSPIRE Study: I. Assessment of spinal measures. J Rheumatol 2007, 34:1733\u20131739.","journal-title":"J Rheumatol"},{"key":"39_CR8","first-page":"2463","volume":"34","author":"V. Chandran","year":"2007","unstructured":"Chandran V, O\u2019shea FD, Schentag CT, et al.: Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a comparative analysis. J Rheumatol 2007, 34:2463\u20132465.","journal-title":"J Rheumatol"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.24280","volume":"61","author":"J.L. Fernandez-Sueiro","year":"2009","unstructured":"Fernandez-Sueiro JL, Willisch A, Pertega-Diaz S, et al.: Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009, 61:386\u2013392.","journal-title":"Arthritis Rheum"},{"key":"39_CR10","first-page":"946","volume":"17","author":"L.H. Daltroy","year":"1990","unstructured":"Daltroy LH, Larson MG, Roberts NW, Liang MH: A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990, 17:946\u2013950.","journal-title":"J Rheumatol"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1002\/art.20549","volume":"50","author":"F. Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K, Pincus T: Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004, 50:3296\u20133305.","journal-title":"Arthritis Rheum"},{"key":"39_CR12","first-page":"1613","volume":"35","author":"Y.Y. Leung","year":"2008","unstructured":"Leung YY, Tam LS, Kun EW, et al.: Comparison of 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using Rasch analyses. J Rheumatol 2008, 35:1613\u20131621.","journal-title":"J Rheumatol"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.51.1.73","volume":"51","author":"C. Salvarani","year":"1992","unstructured":"Salvarani C, Macchioni P, Cremonesi T, et al.: The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 1992, 51:73\u201377.","journal-title":"Ann Rheum Dis"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3899\/jrheum.080491","volume":"36","author":"E. Lubrano","year":"2009","unstructured":"Lubrano E, Marchesoni A, Olivieri I, et al.: Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol 2009, 36:1006\u20131011.","journal-title":"J Rheumatol"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/keg475","volume":"43","author":"L. Williamson","year":"2004","unstructured":"Williamson L, Dockerty JL, Dalbeth N, et al.: Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by MRI in psoriatic arthritis. Rheumatology (Oxford) 2004, 43:85\u201388.","journal-title":"Rheumatology (Oxford)"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.10934","volume":"48","author":"B. Muche","year":"2003","unstructured":"Muche B, Bollow M, Francois RJ, et al.: Anatomic structures involved in early- and late-stage sacroiliitis in spondyloarthritis. A detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 2003, 48:1374\u20131384.","journal-title":"Arthritis Rheum"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","volume":"48","author":"J. Braun","year":"2003","unstructured":"Braun J, Baraliakos X, Golder W, et al.: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003, 48:1126\u20131136.","journal-title":"Arthritis Rheum"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar1934","volume":"8","author":"F. McQueen","year":"2006","unstructured":"McQueen F, Lassere M, \u00d8stergaard M: Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006, 8:207\u2013214.","journal-title":"Arthritis Res Ther"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","volume":"42","author":"N.J. McHugh","year":"2003","unstructured":"McHugh NJ, Balachrishnan C, Jones SM: Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology 2003, 42:778\u2013783.","journal-title":"Rheumatology"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.2008.089441","volume":"68","author":"D.D. Gladman","year":"2009","unstructured":"Gladman DD, Schentag CT, Tom BD, et al.: Psoriatic Arthritis Screen (ToPAS) questionnaire for psoriatic arthritis: the Toronto Development and initial validation of a screening. Ann Rheum Dis 2009, 68:497\u2013501.","journal-title":"Ann Rheum Dis"},{"key":"39_CR21","doi-asserted-by":"crossref","unstructured":"Dagfinrud H, Kvien TK, Hagen KB: Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2004, CD002822. doi:10.1002\/14651858. CD002822.pub2.","DOI":"10.1002\/14651858"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/art.1790070208","volume":"7","author":"A. Hidding","year":"1994","unstructured":"Hidding A, van der Linden S, Gielen X, et al.: Continuation of group physical therapy is necessary in ankylosing spondylitis: results of a randomized controlled trial. Arthritis Care Res 1994, 7:90\u201396.","journal-title":"Arthritis Care Res"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A. Wanders","year":"2005","unstructured":"Wanders A, Heijde D, Landew\u00e9 R, et al.: Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005, 52:1756\u20131765.","journal-title":"Arthritis Rheum"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.20985","volume":"52","author":"D. Heijde van der","year":"2005","unstructured":"van der Heijde D, Baraf HS, Ramos-Remus C, et al.: Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthritis Rheum 2005, 52:1205\u20131215.","journal-title":"Arthritis Rheum"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/03009749209095085","volume":"21","author":"N.D. Peters","year":"1992","unstructured":"Peters ND, Ejstrup L: Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol 1992, 21:134\u2013138.","journal-title":"Scand J Rheumatol"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780240521","volume":"24","author":"G. Mintz","year":"1981","unstructured":"Mintz G, Enr\u00edquez RD, Mercado U, et al.: Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis. Arthritis Rheum 1981, 24:734\u2013736.","journal-title":"Arthritis Rheum"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.1780391209","volume":"39","author":"D.O. Clegg","year":"1996","unstructured":"Clegg DO, Reda DJ, Weisman MH, et al.: Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veteran Affairs Cooperative Study. Arthritis Rheum 1996, 39:2004\u20132012.","journal-title":"Arthritis Rheum"},{"key":"39_CR28","first-page":"723","volume":"27","author":"B.J. Dekker-Saeys","year":"2000","unstructured":"Dekker-Saeys BJ, Dijkmans BA, Tytgat GN: Treatment of spondyloarthropathy with 5 aminosalicylic acid (mesalazine): an open trial. J Rheumatol 2000, 27:723\u2013726.","journal-title":"J Rheumatol"},{"key":"39_CR29","first-page":"1568","volume":"31","author":"L. Gonzalez-Lopez","year":"2004","unstructured":"Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez-Del-Mercado M, et al.: Efficacy of methotrexate in ankylosing spondylitis. A randomized, double blind, placebo controlled trial. J Rheumatol 2004, 31:1568\u20131574.","journal-title":"J Rheumatol"},{"key":"39_CR30","first-page":"98","volume":"49","author":"K. Grasedyck","year":"1990","unstructured":"Grasedyck K, Schattenkirchner M, Bandilla K: The treatment of ankylosing spondylitis with auranofin (Ridaura). Z Rheumatol 1990, 49:98\u201399.","journal-title":"Z Rheumatol"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/rheumatology\/29.4.280","volume":"29","author":"J. Palit","year":"1990","unstructured":"Palit J, Hill J, Capell HA, et al.: A multicentre double blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990, 29:280\u2013283.","journal-title":"Br J Rheumatol"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/36.1.95","volume":"36","author":"G. Jones","year":"1997","unstructured":"Jones G, Crotty M, Brooks P: Psoriatic arthritis: a quantitative overview of therapeutic options. Psoriatic Arthritis Meta-Analysis Study Group. Br J Rheumatol 1997, 36:95\u201399.","journal-title":"Br J Rheumatol"},{"key":"39_CR33","first-page":"2627","volume":"30","author":"J.C. Wei","year":"2003","unstructured":"Wei JC, Chan TW, Lin HS, et al.: Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol 2003, 30:2627\u20132631.","journal-title":"J Rheumatol"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","volume":"50","author":"J.P. Kaltwasser","year":"2004","unstructured":"Kaltwasser JP, Nash P, Gladman D, et al.: Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004, 50:1939\u20131950.","journal-title":"Arthritis Rheum"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/ard.2005.036491","volume":"64","author":"J.C. Denderen van","year":"2005","unstructured":"van Denderen JC, van der Paardt M, Nurmohamed MT, et al.: Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis. Ann Rheum Dis 2005, 64:1761\u20131764.","journal-title":"Ann Rheum Dis"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0049-0172(97)80035-2","volume":"27","author":"I. Olivieri","year":"1997","unstructured":"Olivieri I, Salvarani C, Cantini F, et al.: Therapy with cyclosporine in psoriatic arthritis. Semin Arthritis Rheum 1997, 27:36\u201343.","journal-title":"Semin Arthritis Rheum"},{"key":"39_CR37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2004.024463","volume":"64","author":"A.D. Fraser","year":"2005","unstructured":"Fraser AD, van Kuijk AW, Westhovens R, et al.: A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus cyclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005, 64:859\u2013864.","journal-title":"Ann Rheum Dis"},{"key":"39_CR38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.10139","volume":"46","author":"W.P. Maksymowych","year":"2002","unstructured":"Maksymowych WP, Jhangri GS, Fitzgerald AA, et al.: A six-month randomized, controlled, double-blind, doseresponse comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 2002, 46:766\u2013773.","journal-title":"Arthritis Rheum"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/ard.2004.020800","volume":"63","author":"A.L. Tan","year":"2004","unstructured":"Tan AL, Marzo-Ortega H, O\u2019Connor P, et al.: Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 2004, 63:1041\u20131045.","journal-title":"Ann Rheum Dis"},{"key":"39_CR40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.21870","volume":"54","author":"P.J. Mease","year":"2006","unstructured":"Mease PJ, Gladman DD, Keystone EC, on behalf of the Alefacept in Psoriatic Arthritis Study Group: Alefacept in combination with methotrexate for the treatment of psoriatic arthritis results of a randomized, doubleblind, placebo-controlled study. Arthritis Rheum 2006, 54:1638\u20131645.","journal-title":"Arthritis Rheum"},{"key":"39_CR41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"P.J. Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, et al.: Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000, 356:385\u2013390.","journal-title":"Lancet"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","volume":"50","author":"P.J. Mease","year":"2004","unstructured":"Mease PJ, Kivitz AJ, Burch FX, et al.: Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004, 50:2264\u20132272.","journal-title":"Arthritis Rheum"},{"key":"39_CR43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","volume":"52","author":"C.E. Antoni","year":"2005","unstructured":"Antoni CE, Kavanaugh A, Kirkham B, et al.: Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Arthritis Rheum 2005, 52:1227\u20131236.","journal-title":"Arthritis Rheum"},{"key":"39_CR44","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","volume":"52","author":"P.J. Mease","year":"2005","unstructured":"Mease PJ, Gladman DD, Ritchlin CT, et al.: Adalimumab for the treatment of psoriasis with moderately to severely active psoriatic arthritis. Arthritis Rheum 2005, 52:3279\u20133289.","journal-title":"Arthritis Rheum"},{"key":"39_CR45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","volume":"60","author":"A. Kavanaugh","year":"2009","unstructured":"Kavanaugh A, McInnes I, Mease P, et al.: Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 2009, 60:976\u2013986.","journal-title":"Arthritis Rheum"},{"key":"39_CR46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2007.073569","volume":"66","author":"F. Conti","year":"2007","unstructured":"Conti F, Ceccarelli F, Marocchi E, et al.: Switching tumour necrosis factor-a antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period. Ann Rheum Dis 2007, 66:1393\u20131397.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0039-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0039-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0039-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:51Z","timestamp":1559436591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0039-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0039-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}